CN106236173A - 一种复合型生物套管及其制备方法和应用 - Google Patents
一种复合型生物套管及其制备方法和应用 Download PDFInfo
- Publication number
- CN106236173A CN106236173A CN201610565446.8A CN201610565446A CN106236173A CN 106236173 A CN106236173 A CN 106236173A CN 201610565446 A CN201610565446 A CN 201610565446A CN 106236173 A CN106236173 A CN 106236173A
- Authority
- CN
- China
- Prior art keywords
- biological
- cannula
- duct
- nerve
- slow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 210000005036 nerve Anatomy 0.000 claims abstract description 39
- 239000000463 material Substances 0.000 claims abstract description 36
- 239000003094 microcapsule Substances 0.000 claims abstract description 27
- 230000012010 growth Effects 0.000 claims abstract description 25
- 210000000578 peripheral nerve Anatomy 0.000 claims abstract description 23
- 239000004005 microsphere Substances 0.000 claims description 45
- 238000013268 sustained release Methods 0.000 claims description 38
- 239000012730 sustained-release form Substances 0.000 claims description 38
- 108010025020 Nerve Growth Factor Proteins 0.000 claims description 20
- 229920001661 Chitosan Polymers 0.000 claims description 18
- 102000015336 Nerve Growth Factor Human genes 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 229940053128 nerve growth factor Drugs 0.000 claims description 8
- 238000009987 spinning Methods 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 238000006065 biodegradation reaction Methods 0.000 claims description 6
- 230000007774 longterm Effects 0.000 claims description 6
- 229920002101 Chitin Polymers 0.000 claims description 5
- 229920000954 Polyglycolide Polymers 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 5
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 5
- 239000004633 polyglycolic acid Substances 0.000 claims description 5
- 239000004626 polylactic acid Substances 0.000 claims description 5
- 230000001737 promoting effect Effects 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 claims description 4
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 4
- 108010035532 Collagen Proteins 0.000 claims description 4
- 229940077737 brain-derived neurotrophic factor Drugs 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- 230000006378 damage Effects 0.000 claims description 4
- 238000004945 emulsification Methods 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 230000006196 deacetylation Effects 0.000 claims description 3
- 238000003381 deacetylation reaction Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000011260 aqueous acid Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000000052 vinegar Substances 0.000 claims description 2
- 235000021419 vinegar Nutrition 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 208000010886 Peripheral nerve injury Diseases 0.000 abstract description 5
- 210000004027 cell Anatomy 0.000 description 13
- 230000007547 defect Effects 0.000 description 10
- 230000008439 repair process Effects 0.000 description 10
- 210000002972 tibial nerve Anatomy 0.000 description 9
- 239000003814 drug Substances 0.000 description 8
- 210000003666 myelinated nerve fiber Anatomy 0.000 description 8
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 230000008569 process Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 230000001537 neural effect Effects 0.000 description 6
- 210000003497 sciatic nerve Anatomy 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 5
- 229910021641 deionized water Inorganic materials 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000004677 Nylon Substances 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 210000003022 colostrum Anatomy 0.000 description 4
- 235000021277 colostrum Nutrition 0.000 description 4
- 230000007831 electrophysiology Effects 0.000 description 4
- 238000002001 electrophysiology Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 229920001778 nylon Polymers 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 102000007072 Nerve Growth Factors Human genes 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000001186 cumulative effect Effects 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 239000003900 neurotrophic factor Substances 0.000 description 3
- -1 phosphate ester Chemical class 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 230000001172 regenerating effect Effects 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- 102000006386 Myelin Proteins Human genes 0.000 description 2
- 108010083674 Myelin Proteins Proteins 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000002242 deionisation method Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 238000000556 factor analysis Methods 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 210000005012 myelin Anatomy 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000011056 performance test Methods 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229940068984 polyvinyl alcohol Drugs 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- 230000001228 trophic effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- JRMAQQQTXDJDNC-UHFFFAOYSA-N 2-ethoxy-2-oxoacetic acid Chemical compound CCOC(=O)C(O)=O JRMAQQQTXDJDNC-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000327799 Thallomys paedulcus Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- UNFKZTZHKGFCRC-UHFFFAOYSA-N acetyl acetate;methanol Chemical compound OC.CC(=O)OC(C)=O UNFKZTZHKGFCRC-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229940096422 collagen type i Drugs 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 210000004498 neuroglial cell Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920006149 polyester-amide block copolymer Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/11—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
- A61B17/1128—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis of nerves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00893—Material properties pharmaceutically effective
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/622—Microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
实施例 | 功能评分最优组 | 溃疡状况 | 神经电生理检测值 |
1 | 20mm | 无 | 32.17m/s |
2 | 4mm | 无 | 32.15m/s |
3 | 18cm | 无 | 31.98m/s |
4 | 15cm | 无 | 32.33m/s |
5 | 10mm | 无 | 32.05m/s |
6 | 10cm | 无 | 32.82m/s |
7 | 15cm | 无 | 32.20m/s |
对比例1 | 3cm | 无 | 32.66m/s |
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610565446.8A CN106236173A (zh) | 2016-07-18 | 2016-07-18 | 一种复合型生物套管及其制备方法和应用 |
HK17105232.8A HK1231356A1 (zh) | 2016-07-18 | 2017-05-23 | 種複合型生物套管及其製備方法和應用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610565446.8A CN106236173A (zh) | 2016-07-18 | 2016-07-18 | 一种复合型生物套管及其制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106236173A true CN106236173A (zh) | 2016-12-21 |
Family
ID=57613365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610565446.8A Pending CN106236173A (zh) | 2016-07-18 | 2016-07-18 | 一种复合型生物套管及其制备方法和应用 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN106236173A (zh) |
HK (1) | HK1231356A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107811752A (zh) * | 2017-09-21 | 2018-03-20 | 温州医科大学 | 一种生物相容性青光眼房水引流管及其制备方法 |
CN108324991A (zh) * | 2018-05-16 | 2018-07-27 | 王辉 | 一种缓释GDNF-SCs复合脱细胞神经支架 |
CN110236618A (zh) * | 2018-03-09 | 2019-09-17 | 北京大学人民医院 | 两端不同内径的新型神经套接缝合导管 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030060836A1 (en) * | 2000-12-05 | 2003-03-27 | Shu Wang | Polymer and nerve guide conduits formed thereof |
CN202699192U (zh) * | 2012-04-12 | 2013-01-30 | 北京汇福康医疗技术有限公司 | 一种复合型生物套管 |
-
2016
- 2016-07-18 CN CN201610565446.8A patent/CN106236173A/zh active Pending
-
2017
- 2017-05-23 HK HK17105232.8A patent/HK1231356A1/zh unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030060836A1 (en) * | 2000-12-05 | 2003-03-27 | Shu Wang | Polymer and nerve guide conduits formed thereof |
CN202699192U (zh) * | 2012-04-12 | 2013-01-30 | 北京汇福康医疗技术有限公司 | 一种复合型生物套管 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107811752A (zh) * | 2017-09-21 | 2018-03-20 | 温州医科大学 | 一种生物相容性青光眼房水引流管及其制备方法 |
CN110236618A (zh) * | 2018-03-09 | 2019-09-17 | 北京大学人民医院 | 两端不同内径的新型神经套接缝合导管 |
CN110236618B (zh) * | 2018-03-09 | 2023-09-08 | 北京大学人民医院 | 两端不同内径的新型神经套接缝合导管 |
CN108324991A (zh) * | 2018-05-16 | 2018-07-27 | 王辉 | 一种缓释GDNF-SCs复合脱细胞神经支架 |
Also Published As
Publication number | Publication date |
---|---|
HK1231356A1 (zh) | 2017-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106913393B (zh) | 一种人工神经支架及其制备方法与应用 | |
Park et al. | Functional recovery guided by an electrospun silk fibroin conduit after sciatic nerve injury in rats | |
CN102525689B (zh) | 取向纳米纤维仿生神经导管及其制作方法 | |
CN105079883B (zh) | 一种多级纳米纤维复合可载药牙周组织材料及其制备方法 | |
US20210402065A1 (en) | Functionally Gradient Material for Guided Periodontal Hard and Soft Tissue Regeneration and A Preparation Method Thereof | |
CN105107012B (zh) | 一种复合静电纺丝纳米纤维膜及其制备方法和应用 | |
WO2015074176A1 (zh) | 用于组织再生的亲水性静电纺生物复合支架材料及其制法与应用 | |
CN107715174B (zh) | 一种含微孔隙和纳米纤维复合结构的仿生组织工程支架及其制备方法 | |
CN102743796B (zh) | 用聚乙烯醇制成的丝素蛋白多孔支架及其制备方法和用途 | |
CN112494463B (zh) | 一种小檗碱/矿化胶原复合膜及其制备方法和应用 | |
CN1733311A (zh) | 一种包裹药物或生长因子的纳米纤维的制备方法 | |
CN105597162B (zh) | 一种纳米纤维组织填充物及其制备方法 | |
CN109381732A (zh) | 负载生长因子小分子抑制剂的静电纺丝敷料、其制备方法及应用 | |
CN106236173A (zh) | 一种复合型生物套管及其制备方法和应用 | |
CN109663142B (zh) | 一种载药可降解手术缝纫线及其制备方法 | |
CN103127548A (zh) | 促进神经缺损修复的人工神经导管的制备方法 | |
WO2020062976A1 (zh) | 一种具有生物活性的可降解手术缝线及其制备方法 | |
CN112972760A (zh) | 一种负载内皮细胞外基质的3d打印骨缺损修复支架及其制备方法 | |
CN102133432A (zh) | 一种丝素蛋白微孔支架的制备方法 | |
Wang et al. | Elastic fiber-Reinforced silk fibroin scaffold with a Double-Crosslinking network for human ear-shaped cartilage regeneration | |
CN103371857A (zh) | 复合型生物套管及其制备方法和应用 | |
JP7444409B2 (ja) | ゼラチン短繊維、その製造方法、それを含む細胞凝集体、細胞凝集体の製造方法及び作製キット | |
CN103993425A (zh) | 一种聚己内酯-角蛋白复合纳米纤维膜的制备方法 | |
CN101219238A (zh) | 复合生物可降解合成高分子材料 | |
CN104287869B (zh) | 一种用于气管移植的新型纳米纤维膜/纱支架及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: In Beijing economic and Technological Development Zone, two street 100176 8 Beijing City Hospital No. 18 building 3 layer, 4 layer, 5 layer 504-520 room Applicant after: Beijing 3H Medical Technology Co., Ltd. Address before: 100176 Daxing District Beijing economic and Technological Development Zone, Kangding street, No. 11, building No. 20 Applicant before: Beijing 3H Medical Technology Co., Ltd. |
|
CB02 | Change of applicant information | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1231356 Country of ref document: HK |
|
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161221 |
|
RJ01 | Rejection of invention patent application after publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1231356 Country of ref document: HK |